752 results on '"Taube, Christian"'
Search Results
2. Case Series: Hyperbilirubinemia under elexacaftor/tezacaftor/ivacaftor in the presence of Gilbert’s syndrome
3. Elexacaftor/tezacaftor/ivacaftor influences body composition in adults with cystic fibrosis: a fully automated CT-based analysis
4. Body composition impacts outcome of bronchoscopic lung volume reduction in patients with severe emphysema: a fully automated CT-based analysis
5. Long-term multicenter comparison shows equivalent efficacy of monoclonal antibodies in severe asthma therapy
6. Microbes little helpers and suppliers for therapeutic asthma approaches
7. Editorial: The evolving landscape of asthma: recent advances and challenges
8. Olfactory receptors impact pathophysiological processes of lung diseases in bronchial epithelial cells
9. Therapeutic properties of Helicobacter pylori-derived vacuolating cytotoxin A in an animal model of chronic allergic airway disease
10. EVELUT®: A Real-World, Observational Study Assessing Dyspnoea and Symptom Burden in COPD Patients Switched from LABA/ICS to LAMA/LABA or LAMA/LABA/ICS
11. Plasma levels of chemokines decrease during elexacaftor/tezacaftor/ivacaftor therapy in adults with cystic fibrosis
12. Treatment of Staphylococcus aureus infection with sphingosine in ex vivo perfused and ventilated lungs
13. The molecular mechanisms of remodeling in asthma, COPD and IPF with a special emphasis on the complex role of Wnt5A
14. Initiation, response assessment, and switch of antibody therapies in patients with severe asthma – A survey among German specialists
15. Characterization of Austrian severe asthma patients
16. Characterization of Obesity in Severe Asthma in the German Asthma Net
17. Early Detection of Lung Cancer Using Small RNAs
18. Incidence of malignancies after lung transplantation and their effect on the outcome. 26 years' experience
19. Response to Biologics and Clinical Remission in the Adult German Asthma Net Severe Asthma Registry Cohort
20. Impact of Initiating Biologics in Patients With Severe Asthma on Long-Term Oral Corticosteroids or Frequent Rescue Steroids (GLITTER): Data From the International Severe Asthma Registry
21. Patient preferences in obstructive sleep apnea—a discrete choice experiment
22. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
23. Influence of the early-life gut microbiota on the immune responses to an inhaled allergen
24. IL-9 and IL-9 receptor expression in lymphocytes from bronchoalveolar lavage fluid of patients with interstitial lung disease
25. Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma
26. Treatment preferences and willingness to pay in patients with obstructive sleep apnea: relevance of treatment experience
27. Cough suppression and HRQoL in adult people with cystic fibrosis: an unexplored correlation
28. Obstructive sleep apnea and nocturnal hypoxemia in adult patients with cystic fibrosis
29. Investigation of respiratory rate in patients with cystic fibrosis using a minimal-impact biomotion system
30. Practical guide to cardiopulmonary exercise testing in adults
31. The German severe asthma patient: Baseline characteristics of patients in the German Severe Asthma Registry, and relationship with exacerbations and control
32. S. mansoni -derived omega-1 prevents OVA-specific allergic airway inflammation via hampering of cDC2 migration.
33. Seasonal Patterns of Common Respiratory Viral Infections in Immunocompetent and Immunosuppressed Patients.
34. Proof of principle study: diagnostic accuracy of a novel algorithm for the estimation of sleep stages and disease severity in patients with sleep-disordered breathing based on actigraphy and respiratory inductance plethysmography
35. Defining a Severe Asthma Super-Responder: Findings from a Delphi Process
36. Pseudomonas aeruginosa infection, but not mono or dual-combination CFTR modulator therapy affects circulating regulatory T cells in an adult population with cystic fibrosis
37. Sleep assessment in cystic fibrosis patients using a minimal-impact biomotion system
38. Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial
39. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial
40. Association between habitual physical activity (HPA) and sleep quality in patients with cystic fibrosis
41. Oral corticosteroid prescription for asthma by general practitioners: A three-year analysis in Germany
42. A novel minimal-contact biomotion method for long-term respiratory rate monitoring
43. Severe allergic reactions after COVID-19 vaccination with the Pfizer/BioNTech vaccine in Great Britain and USA: Position statement of the German Allergy Societies: Medical Association of German Allergologists (AeDA), German Society for Allergology and Clinical Immunology (DGAKI) and Society for Pediatric Allergology and Environmental Medicine (GPA)
44. Assessment of Patient Experiences with Respimat® in Everyday Clinical Practice
45. What about the others: differential diagnosis of COVID-19 in a German emergency department
46. Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF
47. Expression pattern of co-inhibitory molecules on CMV-specific T-cells in lung transplant patients
48. Mast cells drive IgE-mediated disease but might be bystanders in many other inflammatory and neoplastic conditions
49. A Prospective, Randomized Trial for the Comparison of 19-G and 22-G Endobronchial Ultrasound-Guided Transbronchial Aspiration Needles; Introducing a Novel End Point of Sample Weight Corrected for Blood Content
50. Transmaternal Helicobacter pylori exposure reduces allergic airway inflammation in offspring through regulatory T cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.